| 000 | 04719cam a2200709 a 4500 | ||
|---|---|---|---|
| 001 | ocn769289644 | ||
| 003 | OCoLC | ||
| 005 | 20220701010928.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 111222s2012 nju ob 001 0 eng | ||
| 010 | _a 2011052987 | ||
| 040 |
_aDLC _beng _epn _cDLC _dEBLCP _dIDEBK _dN$T _dDG1 _dYDXCP _dE7B _dSTF _dCOO _dUBY _dNLGGC _dOCLCF _dOCLCQ _dOCLCO _dOCLCQ _dOCLCO _dOCLCQ _dOCLCO _dDEBBG _dAZK _dOCLCQ _dLOA _dOCLCO _dOCLCA |
||
| 019 |
_a795894798 _a798698963 _a808669946 _a817089457 _a961501567 _a962591718 _a966253987 |
||
| 020 |
_a9781118309407 _q(epub) |
||
| 020 |
_a1118309405 _q(epub) |
||
| 020 |
_a9781118309384 _q(epdf) |
||
| 020 |
_a1118309383 _q(epdf) |
||
| 020 |
_a9781118309391 _q(emobi) |
||
| 020 |
_a1118309391 _q(emobi) |
||
| 020 |
_a9781118309421 _q(electronic bk.) |
||
| 020 |
_a1118309421 _q(electronic bk.) |
||
| 020 | _a1280699310 | ||
| 020 | _a9781280699313 | ||
| 020 |
_a0470322829 _q(cloth) |
||
| 020 |
_a9780470322826 _q(cloth) |
||
| 020 |
_z9780470322826 _q(cloth) |
||
| 029 | 1 |
_aAU@ _b000048329675 |
|
| 029 | 1 |
_aDKDLA _b820120-katalog:000599860 |
|
| 029 | 1 |
_aNZ1 _b14693634 |
|
| 029 | 1 |
_aDEBBG _bBV043393917 |
|
| 035 |
_a(OCoLC)769289644 _z(OCoLC)795894798 _z(OCoLC)798698963 _z(OCoLC)808669946 _z(OCoLC)817089457 _z(OCoLC)961501567 _z(OCoLC)962591718 _z(OCoLC)966253987 |
||
| 037 |
_a10.1002/9781118309421 _bWiley InterScience _nhttp://www3.interscience.wiley.com |
||
| 042 | _apcc | ||
| 050 | 0 | 0 | _aRC514 |
| 060 | 1 | 0 | _aWM 203 |
| 072 | 7 |
_aPSY _x022050 _2bisacsh |
|
| 082 | 0 | 0 |
_a616.89/8061 _223 |
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aTargets and emerging therapies for schizophrenia / _cedited by Jeffrey S. Albert, Michael W. Wood. |
| 260 |
_aHoboken, New Jersey : _bJohn Wiley & Sons, _c©2012. |
||
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_adata file _2rda |
||
| 380 | _aBibliography | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aDopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek [and others] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson [and others] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder [and others] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard. | |
| 588 | 0 | _aPrint version record and CIP data provided by publisher. | |
| 650 | 0 |
_aSchizophrenia _xTreatment. |
|
| 650 | 2 |
_aSchizophrenia _xdrug therapy. |
|
| 650 | 7 |
_aPSYCHOLOGY _xPsychopathology _xSchizophrenia. _2bisacsh |
|
| 650 | 7 |
_aSchizophrenia _xTreatment. _2fast _0(OCoLC)fst01106780 |
|
| 655 | 4 | _aElectronic books. | |
| 655 | 7 |
_aElectronic books. _2local |
|
| 700 | 1 | _aAlbert, Jeffrey S. | |
| 700 | 1 |
_aWood, Michael W. _q(Michael William), _d1961- |
|
| 776 | 0 | 8 |
_iPrint version: _tTargets and emerging therapies for schizophrenia. _dHoboken, N.J. : John Wiley & Sons, ©2012 _z9780470322826 _w(DLC) 2011051091 |
| 856 | 4 | 0 |
_uhttp://dx.doi.org/10.1002/9781118309421 _zWiley Online Library |
| 994 |
_a92 _bDG1 |
||
| 999 |
_c20769 _d20728 |
||